Search results
May 20, 2024 · Our results show significant genetic diversity among dengue virus variants that circulated on the island over the past decade. This diversity indicates the simultaneous presence of multiple lineages and closely related viruses, which may have resulted from regular introductions of new variants.
May 4, 2024 · A lethal model of disseminated dengue virus type 1 infection in AG129 mice. J. Gen. Virol. 2017, 98, 2507–2519. [Google Scholar] Milligan, G.N.; Sarathy, V.V.; Infante, E.; Li, L.; Campbell, G.A.; Beatty, P.R.; Harris, E.; Barrett, A.D.; Bourne, N. A dengue virus type 4 model of disseminated lethal infection in AG129 mice.
May 9, 2024 · 9 May 2024. Vol 384, Issue 6696. pp. 639 - 646. DOI: 10.1126/science.adj4427. Editor’s summary. Dengue, a mosquito-borne flavivirus disease, now affects nearly half of the world’s population.
May 24, 2024 · (2017) The dengue virus non-structural protein 1 (NS1) is secreted from infected mosquito cells via a non-classical caveolin-1-dependent pathway The Journal of General Virology 98 :2088–2099. https://doi.org/10.1099/jgv.0.000881
3 days ago · Dengue virus (DENV) poses a significant threat to global health, infecting approximately 390 million people annually. This virus comprises four serotypes capable of causing severe disease. Genetic analyses are crucial for understanding the epidemiology, evolution, and spread of DENV. Although previous studies have focused on the envelope protein-coding (E) gene, only a few primers can ...
May 7, 2024 · End points were the appearance of any outcome of interest, end of the study (ie, end of 2017), and death. The primary objective was to investigate whether dengue fever was associated with increased risk of neurological or psychiatric disorders. We excluded patients with preexisting conditions or who were younger than 18 years.
May 22, 2024 · In conclusion, our study highlights the potential of the Celcradle™ bioreactor for large-scale production of inactivated dengue virus vaccines, offering significant promise for reducing the global impact of dengue virus infections and accelerating the development of effective vaccination strategies.
